Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Summary
The PASTEUR Act would allow the Secretary of Health to sign contracts with companies that produce antimicrobial drugs targeting urgent or serious threats and that meet unmet medical needs. It establishes a scoring system that rates drugs on clinical benefit, innovation, and public‑health impact, and provides annual payments to those that meet a minimum score. The aim is to spur research, guarantee access, and boost national health and defense readiness.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get real-time alerts when HR 7352 changes status, plus AI-powered summaries and stage predictions.
Sign up free